PhRMA FDA REFORM EFFORT WILL INCLUDE CALL FOR POLICY & PERFORMANCE REVIEW COMMISSION; LEGISLATIVE PROPOSAL BEING CIRCULATED FOR "INPUT AND COMMENT"
Executive Summary
PhRMA's FDA reform legislative proposal will call for the creation of a Policy and Performance Review Commission charged with evaluating FDA's performance relative to international drug regulatory bodies, Pharmaceutical Research & Manufacturers of America General Counsel Russell Bantham told a May 23 meeting of the Food & Drug Law Institute in Washington, D.C.